Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 25,459 shares at $77.63 ($2.0M) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Seasonal sale ($2.0M) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.63 | 5,861 | $455K | 22.7% |
| 2 | $78.61 | 10,465 | $823K | 41.1% |
| 3 | $79.25 | 9,133 | $724K | 36.2% |
| Total | $78.61 avg | 25,459 | $2.0M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |